Back to Agenda
Effective and Balanced Risk Communication
Session Chair(s)
Dolores Montero, DrMed, MD
Head Division Pharmacology and Pharmacoepidemiology
Spanish Agency Of Medicines and Medical Devices, Spain
Risk communication is an essential tool for risk minimisation. This session will provide insight on the patient’s perception, how communication can be tailored to the differences audiences and what are European countries doing in order to improve such communications.
Speaker(s)
Does Transparency in Medicines Information Deliver Benefit to Patients?
D.K.Theo Raynor, PhD, MPharm
University of Leeds, United Kingdom
Professor of Pharmacy Practice
Different Approaches for Different Audiences
Sabine Straus, MD, PhD, MSc
Medicines Evaluation Board (MEB), Netherlands
PRAC Chair, Staff Member
Risk Communication in the EU - The SCOPE Joint Action
Dolores Montero, DrMed, MD
Spanish Agency Of Medicines and Medical Devices, Spain
Head Division Pharmacology and Pharmacoepidemiology
Have an account?